These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 25348669)

  • 1. Validation of DNA methylation to predict outcome in acute myeloid leukemia by use of xMELP.
    Wertheim GB; Smith C; Luskin M; Rager A; Figueroa ME; Carroll M; Master SR
    Clin Chem; 2015 Jan; 61(1):249-58. PubMed ID: 25348669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microsphere-Based Assessment of DNA Methylation for AML Prognosis.
    Wertheim GBW; Luskin MR; Carroll M; Master SR
    Methods Mol Biol; 2017; 1633():125-136. PubMed ID: 28735484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microsphere-based multiplex analysis of DNA methylation in acute myeloid leukemia.
    Wertheim GB; Smith C; Figueroa ME; Kalos M; Bagg A; Carroll M; Master SR
    J Mol Diagn; 2014 Mar; 16(2):207-15. PubMed ID: 24373919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypermethylation of the GATA binding protein 4 (GATA4) promoter in Chinese pediatric acute myeloid leukemia.
    Tao YF; Fang F; Hu SY; Lu J; Cao L; Zhao WL; Xiao PF; Li ZH; Wang NN; Xu LX; Du XJ; Sun LC; Li YH; Li YP; Xu YY; Ni J; Wang J; Feng X; Pan J
    BMC Cancer; 2015 Oct; 15():756. PubMed ID: 26490736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HSC commitment-associated epigenetic signature is prognostic in acute myeloid leukemia.
    Bartholdy B; Christopeit M; Will B; Mo Y; Barreyro L; Yu Y; Bhagat TD; Okoye-Okafor UC; Todorova TI; Greally JM; Levine RL; Melnick A; Verma A; Steidl U
    J Clin Invest; 2014 Mar; 124(3):1158-67. PubMed ID: 24487588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA methylation signatures identify biologically distinct subtypes in acute myeloid leukemia.
    Figueroa ME; Lugthart S; Li Y; Erpelinck-Verschueren C; Deng X; Christos PJ; Schifano E; Booth J; van Putten W; Skrabanek L; Campagne F; Mazumdar M; Greally JM; Valk PJ; Löwenberg B; Delwel R; Melnick A
    Cancer Cell; 2010 Jan; 17(1):13-27. PubMed ID: 20060365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early B-cell factor 3 (EBF3) is a novel tumor suppressor gene with promoter hypermethylation in pediatric acute myeloid leukemia.
    Tao YF; Xu LX; Lu J; Hu SY; Fang F; Cao L; Xiao PF; Du XJ; Sun LC; Li ZH; Wang NN; Su GH; Li YH; Li G; Zhao H; Li YP; Xu YY; Zhou HT; Wu Y; Jin MF; Liu L; Zhu XM; Ni J; Wang J; Xing F; Zhao WL; Pan J
    J Exp Clin Cancer Res; 2015 Jan; 34(1):4. PubMed ID: 25609158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A clinical measure of DNA methylation predicts outcome in de novo acute myeloid leukemia.
    Luskin MR; Gimotty PA; Smith C; Loren AW; Figueroa ME; Harrison J; Sun Z; Tallman MS; Paietta EM; Litzow MR; Melnick AM; Levine RL; Fernandez HF; Luger SM; Carroll M; Master SR; Wertheim GB
    JCI Insight; 2016 Jun; 1(9):. PubMed ID: 27446991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative DNA methylation predicts survival in adult acute myeloid leukemia.
    Bullinger L; Ehrich M; Döhner K; Schlenk RF; Döhner H; Nelson MR; van den Boom D
    Blood; 2010 Jan; 115(3):636-42. PubMed ID: 19903898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant DNA Methylation in Acute Myeloid Leukemia and Its Clinical Implications.
    Yang X; Wong MPM; Ng RK
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31527484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The 5' flanking region of miR-378 is hypomethylated in acute myeloid leukemia.
    Zhu XW; Wen XM; Zhang YY; Yang L; Guo H; Yang J; Zhang M; Yin JY; Ma JC; Lin J; Deng ZQ; Qian J
    Int J Clin Exp Pathol; 2015; 8(5):4321-31. PubMed ID: 26191124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of differentially methylated markers among cytogenetic risk groups of acute myeloid leukemia.
    Qu X; Davison J; Du L; Storer B; Stirewalt DL; Heimfeld S; Estey E; Appelbaum FR; Fang M
    Epigenetics; 2015; 10(6):526-35. PubMed ID: 25996682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased DNA methylation in acute myeloid leukemia patients with DNMT3A mutations and prognostic implications of DNA methylation.
    Hájková H; Marková J; Haškovec C; Sárová I; Fuchs O; Kostečka A; Cetkovský P; Michalová K; Schwarz J
    Leuk Res; 2012 Sep; 36(9):1128-33. PubMed ID: 22749068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical implications of genome-wide DNA methylation studies in acute myeloid leukemia.
    Li Y; Xu Q; Lv N; Wang L; Zhao H; Wang X; Guo J; Chen C; Li Y; Yu L
    J Hematol Oncol; 2017 Feb; 10(1):41. PubMed ID: 28153026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Array-based DNA methylation profiling in acute myeloid leukaemia.
    Wilop S; Fernandez AF; Jost E; Herman JG; Brümmendorf TH; Esteller M; Galm O
    Br J Haematol; 2011 Oct; 155(1):65-72. PubMed ID: 21790528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methylation-independent CHFR expression is a potential biomarker affecting prognosis in acute myeloid leukemia.
    Zhou JD; Zhang TJ; Li XX; Ma JC; Guo H; Wen XM; Yao DM; Zhang W; Lin J; Qian J
    J Cell Physiol; 2018 Jun; 233(6):4707-4714. PubMed ID: 29115660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNMT3A intragenic hypomethylation is associated with adverse prognosis in acute myeloid leukemia.
    Zhang YY; Yao DM; Zhu XW; Zhou JD; Ma JC; Yang J; Wen XM; Guo H; Lin J; Qian J
    Leuk Res; 2015 Oct; 39(10):1041-7. PubMed ID: 26242829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical and prognostic significance of ABO promotor methylation level in adult leukemia and myelodydysplastic syndrome].
    Shao M; Tang P; Lyu XP; Yang QK; Zhu WT; Jin HF; Wang L; Zhao XQ; Liu X; Sun L
    Zhonghua Nei Ke Za Zhi; 2018 Nov; 57(11):816-823. PubMed ID: 30392237
    [No Abstract]   [Full Text] [Related]  

  • 19. NDRG2 and TLR7 as novel DNA methylation prognostic signatures for acute myelocytic leukemia.
    Ge F; Zhang P; Niu J; Pei X; Lian C; Yu R; Ma R; Zhang Y; Zhu Z; Sun K
    J Cell Physiol; 2020 Apr; 235(4):3790-3797. PubMed ID: 31613009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CTNNA1 hypermethylation, a frequent event in acute myeloid leukemia, is independently associated with an adverse outcome.
    Li M; Gao L; Li Z; Sun J; Zhang H; Duan H; Ma Y; Wang C
    Oncotarget; 2016 May; 7(21):31454-65. PubMed ID: 27129146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.